| Localization of topically applied TFPI binding sites in an intimectomized microvessel. | |
| | |
MedLine Citation:
|
PMID: 7740496 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Tissue factor pathway inhibitor, TFPI, has been shown to be highly effective as a topically applied antithrombotic in an arterial model of vascular thrombosis. To elucidate the mechanism and site of TFPI action, recombinant TFPI was conjugated to 30 nm diameter gold particles and used to localize the sites of TFPI binding in a traumatized microvessel by transmission electron microscopy. The model, the central artery of the rabbit ear, was transected, denuded of endothelial lining (intimectomized), and re-anastomosed. Prior to the restoration of blood flow, TFPI-gold or unconjugated gold particles in solution were applied by irrigation to the intimectomized vessel lumen. After 10 min of blood flow, the artery was harvested for electron microscopy. TFPI-gold binding was localized to the fine strands of fibrin that lined the lumen of the intimectomized section of the artery. Little or no binding was found on platelets, exposed smooth muscle, cell membrane fragments, or uninjured vessel segments. The TFPI-gold binding could be competed with native TFPI. TFPI-gold was inhibitory, although less potent than native TFPI, in a prothrombin time assay. Unconjugated gold exhibited very little binding in the vascular model. Hence, the TFPI-gold conjugate behaved like native TFPI. Our observations have identified the fibrin complex as an in vivo binding site for TFPI and suggest that this is an in vivo site of action for TFPI as a topical antithrombotic agent. |
| | |
Authors:
|
R L Ornberg; E G Deune; M R Ozbek; T C Wun; R K Khouri |
Related Documents
:
|
2545726 - Characterization of 125i-tissue plasminogen activator binding to cerebellar granule neu... 23226276 - Kaiso represses the cell cycle gene cyclin d1 via sequence-specific and methyl-cpg-depe... 2961366 - Reactivity of chemically cross-linked fibrinogen and its fragments d toward the staphyl... 9598826 - Binding of human urokinase-type plasminogen activator to its receptor: residues involve... 2606346 - A transcription factor, tfis, interacts with both the promoter and enhancer of the xeno... 1270086 - Subfragmentation of the fc fragment of human igg1 myeloma protein by thermolysin. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Thrombosis and haemostasis Volume: 73 ISSN: 0340-6245 ISO Abbreviation: Thromb. Haemost. Publication Date: 1995 Jan |
Date Detail:
|
Created Date: 1995-06-05 Completed Date: 1995-06-05 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7608063 Medline TA: Thromb Haemost Country: GERMANY |
Other Details:
|
Languages: eng Pagination: 55-8 Citation Subset: IM |
Affiliation:
|
Monsanto Company, St. Louis, MO 63167, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Topical Anastomosis, Surgical Animals Arteries / injuries, metabolism*, surgery, ultrastructure Binding Sites Binding, Competitive Ear, External / blood supply Endothelium, Vascular / injuries Fibrin / metabolism* Gold Humans Lipoproteins / administration & dosage, metabolism* Microscopy, Electron Microsurgery Muscle, Smooth, Vascular / metabolism, ultrastructure Rabbits Recombinant Fusion Proteins / administration & dosage, metabolism Thrombosis / etiology Vascular Surgical Procedures / adverse effects |
| Chemical | |
Reg. No./Substance:
|
0/Lipoproteins; 0/Recombinant Fusion Proteins; 0/lipoprotein-associated coagulation inhibitor; 7440-57-5/Gold; 9001-31-4/Fibrin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in cult...
Next Document: Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation.